Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.

New data highlight how Heartflow's AI software drives major shifts in heart care
One of the study's most significant findings was that patients managed using the advanced AI software saw LDL cholesterol drops of 18.7 mg/dL, with a 15% reduction in their risk of a cardiac event. Even patients with no calcified plaque saw significant changes in care management.
AHA data challenge explores links between inflammation and heart disease
Are care teams doing enough to take on inflammation? The American Heart Association hopes this new research initiative can help answer that question, and many others.
The power of prevention: Cardiologist says proactive patient care can make a big difference later in life
Former ACC president Kim Allan Williams Sr., MD, thinks cardiologists should be much more proactive. Encouraging healthy eating habits now, for example, can keep patients out of the hospital later in life and reduce healthcare spending.
Yes, researchers argue, vitamin D supplements help protect the heart
The ongoing debate continues. The team behind this latest analysis pointed to more than 40 years of research to make its point.
‘The start of a paradigm shift’: FDA clears first over-the-counter cuffless blood pressure monitor
The cuffless technology, which has already gained CE mark approval, should make its U.S. debut in 2026.

Diabetes patients are experiencing fewer heart attacks and strokes as patient care continues to evolve

Patients with diabetes faced a much higher risk of a cardiovascular event in 1994 than they did in 2014, according to a new analysis published in JAMA.

Fish oil, garlic and other ‘heart-healthy’ dietary supplements do not improve cholesterol levels

The new analysis was presented at the AHA Scientific Sessions 2022 conference and simultaneously published in the Journal of the American College of Cardiology.

How the COVID-19 pandemic has impacted blood pressure management in the US

A new analysis of more than 137,000 patients found that the early months of the pandemic were associated with some concerning trends for hypertension patients.

Leslee Shaw, PhD, MSCCT, FACC, MASNC, FAHA, director of the Blavatnik Family Women's Health Research Institute, a professor of medicine at the Icahn School of Medicine at Mount Sinai, and a former president of both SCCT and ASNC. She explains the sex differences in cardiovascular imaging presentations in women versus men.

VIDEO: CT can play a role in identifying women's differences in cardiovascular presentations

Leslee Shaw, PhD, director of the Blavatnik Family Women's Health Research Institute, a professor of medicine at the Icahn School of Medicine at Mount Sinai, and a former president of both SCCT and ASNC, explains the sex differences in cardiovascular imaging presentations in women versus men.

FDA announces new recall of blood pressure medication due to potential cancer risk

Patients impacted by this recall are advised to speak with a physician about how to proceed.

E-cigarettes linked to AFib, other heart rhythm issues in ‘highly concerning’ new study

“The findings of this study are important because they provide fresh evidence that the use of e-cigarettes could interfere with normal heart rhythms—something we did not know before,” according to one specialist.

cocaine heart failure HFrEF LVEF hospitalizations beta-blockers hypertension cardiology

Marijuana, meth, cocaine and opiates all linked to heart rhythm issues

Reviewing data from more than 23.5 million U.S. patients, the study's authors found that methamphetamine use was linked to a whopping 86% increase in a patient's AFib risk. The other substances included in the analysis were not far behind.

Deepak Bhatt, MD, MPH, executive director of the interventional cardiovascular programs at Brigham and Women’s Hospital, and professor of medicine at Harvard Medical School, explained the new generation of cholesterol lowering agents and their roles in various types of patients.

VIDEO: Deepak Bhatt discusses the role of new cholesterol-lowering agents

Deepak Bhatt, MD, a professor of medicine at Harvard Medical School, details the new generation of cholesterol-lowering agents and their roles in patient care.

Heart Health

New data highlight how Heartflow's AI software drives major shifts in heart care

AHA data challenge explores links between inflammation and heart disease

The power of prevention: Cardiologist says proactive patient care can make a big difference later in life

Yes, researchers argue, vitamin D supplements help protect the heart

‘The start of a paradigm shift’: FDA clears first over-the-counter cuffless blood pressure monitor